Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.6	111	134.34	129.32	157.53	92.57
Cash & Short-Term Investments	77.6	111	134.34	129.32	157.53	92.57
Cash Growth	-42.65%	-17.38%	3.89%	-17.91%	70.17%	417.27%
Accounts Receivable	-	-	0.4	4.1	-	-
Other Receivables	-	-	0.95	2.83	-	-
Receivables	-	-	1.35	6.93	-	-
Prepaid Expenses	2.84	2.07	2.47	3.96	3.44	0.34
Restricted Cash	-	-	0.21	-	0.1	-
Total Current Assets	80.44	113.07	138.37	140.2	161.07	92.91
Property, Plant & Equipment	11.11	12.32	14.85	17.45	16.33	3.12
Long-Term Deferred Charges	-	-	-	-	-	0.16
Other Long-Term Assets	1.02	1.54	21.62	2.59	1.86	0.21
Total Assets	92.57	126.93	174.83	160.25	179.25	96.4
Accounts Payable	2.77	3.04	1.34	1.22	2.04	1.02
Accrued Expenses	8.54	10.23	8.41	13.41	8.6	3.49
Current Portion of Long-Term Debt	2.4	-	6.67	-	-	-
Current Portion of Leases	1.45	1.56	1.61	2.08	1.07	0.68
Current Unearned Revenue	-	-	0.91	6.53	-	-
Other Current Liabilities	-	0.36	0.45	0.74	0.16	0.09
Total Current Liabilities	15.17	15.18	19.38	23.99	11.87	5.28
Long-Term Debt	24.71	26.1	32.66	-	-	-
Long-Term Leases	8.59	9.44	10.99	12.6	14.59	1.86
Long-Term Unearned Revenue	-	-	0.43	1.13	-	-
Other Long-Term Liabilities	2.64	2.83	-	0.19	-	0.03
Total Liabilities	51.1	53.54	63.46	37.91	26.46	7.18
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	492.12	487.97	455.44	429.04	405.68	-
Retained Earnings	-450.66	-414.59	-344.07	-306.71	-252.9	-51.87
Total Common Equity	41.46	73.39	111.37	122.34	152.79	-51.86
Shareholders' Equity	41.46	73.39	111.37	122.34	152.79	89.22
Total Liabilities & Equity	92.57	126.93	174.83	160.25	179.25	96.4
Total Debt	37.15	37.09	51.92	14.68	15.66	2.54
Net Cash (Debt)	40.45	73.91	82.42	114.63	141.87	90.03
Net Cash Growth	-58.99%	-10.33%	-28.10%	-19.20%	57.58%	509.99%
Net Cash Per Share	0.91	1.69	2.31	3.97	7.69	89.58
Filing Date Shares Outstanding	45.73	44.83	42.74	35.28	27.65	1.75
Total Common Shares Outstanding	45.34	44.83	39.11	31.52	27.61	1.75
Working Capital	65.27	97.89	118.99	116.21	149.19	87.63
Book Value Per Share	0.91	1.64	2.85	3.88	5.53	-29.70
Tangible Book Value	41.46	73.39	111.37	122.34	152.79	-51.86
Tangible Book Value Per Share	0.91	1.64	2.85	3.88	5.53	-29.70
Machinery	-	3.34	3.16	2.32	1.07	0.64
Construction In Progress	-	-	-	0.11	1.96	-
Leasehold Improvements	-	7.97	7.97	7.97	0.27	0.19

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q